Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Farrell

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Hepatology Communications|February 7, 2018
The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese miceFahrettin Haczeyni, Hans Wang, Vanessa Barn, et al.
Journal of Gastroenterology and Hepatology|February 20, 2009
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expressionGeoffrey C Farrell, Claire Z Larter, Jing Yun Hou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2013
Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotypeGeoffrey C Farrell, Auvro R Mridha, Matthew M Yeh, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Journal of Hepatology|February 8, 2017
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in miceAuvro R Mridha, Alexander Wree, Avril A B Robertson, et al.
Journal of Clinical and Translational Research|February 15, 2019
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axisLianne de Haan, Sarah J van der Lely, Anne-Loes K Warps, et al.
Journal of Hepatology|December 19, 2020
Non-alcoholic fatty liver disease: Not time for an obituary just yet!Shivaram Prasad Singh, Prajna Anirvan, K Rajender Reddy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 19, 2019
The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusionRowan F van Golen, Megan J Reiniers, Gerben Marsman, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Hepatology Communications|February 7, 2018
The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese miceFahrettin Haczeyni, Hans Wang, Vanessa Barn, et al.
Journal of Gastroenterology and Hepatology|February 20, 2009
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expressionGeoffrey C Farrell, Claire Z Larter, Jing Yun Hou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2013
Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotypeGeoffrey C Farrell, Auvro R Mridha, Matthew M Yeh, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Journal of Hepatology|February 8, 2017
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in miceAuvro R Mridha, Alexander Wree, Avril A B Robertson, et al.
Journal of Clinical and Translational Research|February 15, 2019
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axisLianne de Haan, Sarah J van der Lely, Anne-Loes K Warps, et al.
Journal of Hepatology|December 19, 2020
Non-alcoholic fatty liver disease: Not time for an obituary just yet!Shivaram Prasad Singh, Prajna Anirvan, K Rajender Reddy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 19, 2019
The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusionRowan F van Golen, Megan J Reiniers, Gerben Marsman, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 13